.
Industry Insights

A Study Suggests that the IVD Market will continue to Grow Thanks to Coronavirus Testing

A Study Suggests that the IVD Market will continue to Grow Thanks to Coronavirus Testing

Table of Contents:

  1. Text Link
    1. Text Link

What comes next after the Coronavirus testing surge? That question was asked in a recent AACC article authored by Kimberly Scott.

According to a recent study, testing for SARS-CoV-2 is expected to add almost $33 billion to the in vitro diagnostic market in 2022, and although testing is projected to decline, the belief from experts is that COVID will have staying power as an endemic infection for years to come.

To learn more about the study and what it means in terms of molecular diagnostic testing, you are encouraged to click on the link below.

Where Does the IVD Market Go After the Coronavirus Testing Surge?

Related posts

Book Your Demo Today

Meet with our product experts and learn how LigoLab helps clinical labs and pathology practices digitally transform into modern, efficient, and profitable organizations.  
Pick the Solution(s) of Interest:
Сhoose at least one checkbox
We respect your privacy
icon privacy

Thank you!

We will contact you soon!
Oops! Something went wrong while submitting the form.

Book Your Demo Today

Meet with our product experts and learn how LigoLab helps clinical labs and pathology practices digitally transform into modern, efficient, and profitable organizations.  
Pick the Solution(s) of Interest:
Сhoose at least one checkbox
We respect your privacy
icon privacy

Thank you!

We will contact you soon!
Oops! Something went wrong while submitting the form.